News

NADMED is one of ten companies chosen for the Deep Tech Accelerator Funding program. The companies...

NADMED attends the premier international conference on mitochondrial disease EUROMIT 11-15 June....

A recent study with mice suggests NAD+ repletion with niacin counteracts cancer cachexia. The...